Growth factor receptor-mediated signal transduction and PI3K–AKT activation have been implicated in conferring resistance to conventional chemotherapy in breast cancer cells (Yu et al, 1996; Knuefermann et al, 2003). This evidence concerns the gene PIK3CA and breast cancer.